Panacea Venture, a venture capital firm backed by Kleiner Perkins Caufield & Byers (KPCB) China partners James Huang and Hai Mai, has hit the final close of its new healthcare fund in an oversubscribed fundraise at $180.5 million, according to a statement.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com